TY - JOUR
T1 - Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis
AU - O'Dell, J. R.
PY - 1998
Y1 - 1998
N2 - Combinations of DMARDs are currently used to treat rheumatoid arthritis by almost all rheumatologists. This article reviews the published data on the triple combination of methotrexate, sulfasalazine, and hydroxychloroquine, discusses caveats for clinical use, compares efficacy of different combinations, and speculates on future combination therapies.
AB - Combinations of DMARDs are currently used to treat rheumatoid arthritis by almost all rheumatologists. This article reviews the published data on the triple combination of methotrexate, sulfasalazine, and hydroxychloroquine, discusses caveats for clinical use, compares efficacy of different combinations, and speculates on future combination therapies.
UR - http://www.scopus.com/inward/record.url?scp=0031670893&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031670893&partnerID=8YFLogxK
U2 - 10.1016/S0889-857X(05)70020-X
DO - 10.1016/S0889-857X(05)70020-X
M3 - Article
C2 - 9710881
AN - SCOPUS:0031670893
SN - 0889-857X
VL - 24
SP - 465
EP - 477
JO - Rheumatic Disease Clinics of North America
JF - Rheumatic Disease Clinics of North America
IS - 3
ER -